Reportlinker.com announces that a new market research report is
available in its catalogue.
Reportlinker
Adds China Listed Bio-pharmaceutical Companies Report, 2008
http://www.reportlinker.com/p0128698/Reportlinker-Adds-China-Listed-Bio-pharmaceutical-Companies-Report-2008.html
This report firstly gives an overview of China bio-pharmaceutical
industry, and then analyses sub-industries, import & exports status of
the industry; finally it expounds the operations and revenue, project
investment, main business structure, latest development and future trend
of key 20 bio-pharmaceutical companies.
Sales revenue of bio-pharmaceutical industry in Jan-Nov 2008 raised
29.8% compared with the same period of 2007, up 7.6 points; Sales cost
saw a 33.9% YoY rise; and gross profit margin grew 28.2% year-on-year,
down 2.5 percentage points. The rate of period expense was 15.8%, down
1.2 points from the same period of 2007.
In 2008, China exported 1,632.14 tons of human & animal blood products,
antiserum and vaccines, down 29.7% year on year; the export value
totaled US$56.92 million, down 85.3%; the export price per unit was
US$34.87/kg, US$16.96/kg lower than 2007.
In addition, the import volume of human & animal blood products,
antiserum and vaccines amounted to 8,977.90 tons, up 2.87 times; the
import value totaled US$558.16 million, up 44.3%; unit import price was
US$62.17/kg, US$167.37/kg lower than 2007.
1.Overview of China Bio-pharmaceutical Industry, 2008
1.1 Industry Development
1.2 Market
1.2.1 Overview
1.2.2 Sub-industries
1.2.3 Import & Export
2. Shenzhen CAU Technology Co., Ltd (000004)
2.1 Company Profile
2.2 Operations and Revenue
2.3 Investment
2.4 Main Business Structure
2.5 Latest Development and Future Trend
3.Shenzhen Neptunus Bioengineering Co., Ltd (000078)
3.1 Company Profile
3.2 Operations and Revenue
3.3 Investment
3.4 Main Business Structure
3.5 Latest Development and Future Trend
4.Sihuan Pharmaceutical Co., Ltd (000605)
4.1 Company Profile
4.2 Operations and Revenue
4.3 Investment
4.4 Main Business Structure
4.5 Latest Development and Future Trend
5.Changchun High & New Technology Industries (Group) Inc. (000661)
5.1 Company Profile
5.2 Operations and Revenue
5.3 Investment
5.4 Main Business Structure
5.5 Latest Development and Future Trend
6.Chengzhi Co., Ltd (000990)
6.1 Company Profile
6.2 Operations and Revenue
6.3 Investment
6.4 Main Business Structure
6.5 Latest Development and Future Trend
7. Hualan Biological Engineering Inc.(002007)
7.1 Company Profile
7.2 Operations and Revenue
7.3 Investment
7.4 Main Business Structure
7.5 Latest Development and Future Trend
8.Shanghai Kehua Bio-engineering Co., Ltd (002022)
8.1 Company Profile
8.2 Operations and Revenue
8.3 Investment
8.4 Main Business Structure
8.5 Latest Development and Future Trend
9.Da An Gene Co., Ltd (002030)
9.1 Company Profile
9.2 Operations and Revenue
9.3 Investment
9.4 Main Business Structure
9.5 Latest Development and Future Trend
10.Beijing SL Pharmaceutical Co., Ltd (002038)
10.1 Company Profile
10.2 Operations and Revenue
10.3 Investment
10.4 Main Business Structure
10.5 Latest Development and Future Trend
11.Shanghai RAAS Blood Products Co., Ltd (002252)
11.1 Company Profile
11.2 Operations and Revenue
11.3 Investment
11.4 Main Business Structure
11.5 Latest Development and Future Trend
12.Ginwa Enterprise (Group) Co., Ltd (600080)
12.1 Company Profile
12.2 Operations and Revenue
12.3 Investment
12.4 Main Business Structure
12.5 Latest Development and Future Trend
13.Beijing Tiantan Biological Products Co., Ltd (600161)
13. 1 Company Profile
13.2 Operations and Revenue
13.3 Investment
13.4 Main Business Structure
13.5 Latest Development and Future Trend
14.China Animal Husbandry Industry Co., Ltd (600195)
14.1 Company Profile
14.2 Operations and Revenue
14.3 Investment
14.4 Main Business Structure
14.5 Latest Development and Future Trend
15.Shanghai Fosun Pharmaceutical (Group) Co., Ltd (600196)
15.1 Company Profile
15.2 Operations and Revenue
15.3 Investment
15.4 Main Business Structure
15.5 Latest Development and Future Trend
16.Inner Mongolia Jinyu Group Co., Ltd (600201)
16.1 Company Profile
16.2 Operations and Revenue
16.3 Investment
16.4 Main Business Structure
16.5 Latest Development and Future Trend
17.Shanghai Jiao Da Onlly Co., Ltd (600530)
17.1 Company Profile
17.2 Operations and Revenue
17.3 Investment
17.4 Main Business Structure
17.5 Latest Development and Future Trend
18.Beihai Gofar Marine Biological Industry Co., Ltd (600538)
18.1 Company Profile
18.2 Operations and Revenue
18.3 Investment
18.4 Main Business Structure
18.5 Latest Development and Future Trend
19.Zhongyuan Union Stem Cell Bioengineering Co., Ltd (600645)
19.1 Company Profile
19.2 Operations and Revenue
19.3 Investment
19.4 Main Business Structure
19.5 Latest Development and Future Trend
20.Star Lake Bioscience Co., Inc (600866)
20.1 Company Profile
20.2 Operations and Revenue
20.3 Investment
20.4 Main Business Structure
20.5 Latest Development and Future Trend
21.Tonghua Dongbao Pharmaceutical Co., Ltd (600867)
21.1 Company Profile
21.2 Operations and Revenue
21.3 Main Business Structure
21.4 Latest Development and Future Trend
To order this report:
Reportlinker
Adds China Listed Bio-pharmaceutical Companies Report, 2008
http://www.reportlinker.com/p0128698/Reportlinker-Adds-China-Listed-Bio-pharmaceutical-Companies-Report-2008.html
More market research reports here!
Contact:ReportlinkerNicolas: nbo@reportlinker.comUS:
(805)-652-2626Intl: +1 805-652-2626
Next Article: Research and Markets: Airlines Databank â India is a Databank Providing Financial and Operational Data of Each Domestic Airline in India
Previous article: Research and Markets: Turkey Commercial Banking Report Q2 2009 Gives an Account of the Key Changes in Q209 â And What They Mean For Readers